期刊文献+

窒息新生儿血清肌红蛋白和心肌酶联合测定探讨 被引量:1

下载PDF
导出
摘要 目的探讨新生儿窒息后血清肌红蛋白(Mb)和心肌酶测定对心肌损害的诊断价值。方法将80例窒息新生儿按窒息程度分为重度窒息组(30例)和轻度窒息组(50例),另选50例正常足月新生儿作为对照组,对3组新生儿血清Mb及谷丙转氨酶(AST)、乳酸脱氢酶(LDH)、α-羟丁酸脱氢酶(a-HBDH)、肌酸激酶(CK)、肌酸激酶心型同工酶(CK-MB)5项心肌酶指标进行检测。结果窒息新生儿组血清Mb、AST、LDH、α-HBDH、CK、CK-M B水平较对照组明显升高(P<0.01),且重度窒息组明显高于轻度窒息组(P<0.01)。结论血清Mb联合心肌酶测定可作为新生儿窒息后心肌损害的早期监测和诊断指标,为确定治疗方案提供依据。
作者 陈志宏
出处 《卫生职业教育》 2015年第17期148-149,共2页 HEALTH VOCATIONAL EDUCATION
  • 相关文献

参考文献4

二级参考文献21

  • 1[15]Marumoto K, Hamada M, Hiwada K. Increased secretion of atrial and brain natriuretic peptides during acute myocardial ischemia induced by dynamic exercise in patients with angina pectoris. Clin Sci (Lond),1995, 88:551-556.
  • 2[16]Jerberg T, Lindahl B, Siegbahn A, et al. N-terminal pro brain natriuretic peptide in relation to inflammation,myocardial necrosis and the effects of an invasive strategy in unstable coronary artery disease. J Am Coll Cardial, 2003, 42:1909-1916.
  • 3[17]Sato Y, Yamada T, Taniguchi R, et al. Persistently increased serum concentrations of cardiac troponin t in patients with idiopathic dilated cardiomyopathy are predictive of adverse outcomes. Circulation,2001,103:369-374.
  • 4[18]Horwich TB, Patel J, MacLellan RW, et al. Cardiac troponin Ⅰ is associated with impaired hemodynamics,progressive left ventricular dysfunction, and increased mortality in advanced heart failure. Circulation,2003,108: 833-838.
  • 5[19]Venge P, Lagerqvist B, Diderholm E, et al. Clinical performance of three cardiac troponin assays in patients with unstable coronary artery disease (a FRISC Ⅱsubstudy). Am J Cardial, 2002,89:1035-1041.
  • 6[1]Panteghini M. Acute coronary syndrome. Biochemical strategies in the troponin era. Chest, 2002,122:1428-1435.
  • 7[2]Alpert JS, Thygesen K, Antman E,et al. Myocardial infarction redefined consensus document of the Joint European Society of Cardiology/Am college of cardiology committee for the redefinition of myocardial infarction. J Am Coll Cardiol, 2002,36: 959-969.
  • 8[3]Nomenclature and Criteria for Diagnosis of Ischemic Heart Disease. Report of the Joint International Society and Federation of Cardiology/World Health Organization Task Force on Standardization of Clinical Nomenclature. Circulation, 1979,59: 607-608.
  • 9[4]Panteghini M.Role and importance of biochemical markers in clinical cardiology. European Heart Journal,2004, 25:1187-1196.
  • 10[5]Wu AHB. National academy of clinical biochemistry standards of laboratory practice: recommendations for the uso of cardiac markers in coronary artery diseases. Clin Chem, 1999,45: 1104-1121.

共引文献188

同被引文献11

引证文献1

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部